Share

Mexico participates in Walvax COVID-19 vaccine trials

Media Dec 7, 2021 adn40

Trials of the Walvax vaccine against COVID-19 are being carried out in Mexico. The product is based on the mRNA, same as the moderna and pfizer vaccines. It is a biologic developed in China and 6,000 volunteers over 18 years of age are being recruited nationally.

Related Links

Walvax announces the receipt of the purchase order from Morocco for the 13-valent pneumococcal polysaccharide conjugate vaccine

CEPI, Shanghai Zerun Biotech and Walvax Biotech expand collaboration to develop COVID-19 multi-variant vaccine

Walvax and Abogen Granted Indonesian Emergency Use Authorization for the SARS-CoV-2 mRNA Vaccine (AWcorna)